Search results for “CD40” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,101 patents, we discovered top 188 key players by total patent application. Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. are dominant in this area. They take 18.44% of the total patent filing.
New York, United States
Patent: 98
Switzerland
Patent: 68
Jiangsu Sheng, China
Patent: 37
Shanghai Shi, China
Patent: 35
Basel-Stadt, Switzerland
Patent: 31
Israel
Patent: 31
Israel
Patent: 31
Illinois, United States
Patent: 26
Washington, United States
Patent: 26
Tokyo-to, Japan
Patent: 24
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 46 patents, we discovered top 9 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Lyvgen Biopharma Co., Ltd, Hibercell, Inc. are active in this area.
STARTUP
France
Patent: 15
STARTUP
Shanghai Shi, China
Patent: 12
STARTUP
New York, United States
Patent: 6
STARTUP
United Kingdom
Patent: 5
STARTUP
Beijing Shi, China
Patent: 3
STARTUP
Washington, United States
Patent: 2
STARTUP
North Carolina, United States
Patent: 1
STARTUP
Jiangsu Sheng, China
Patent: 1
STARTUP
Zhejiang Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 781 patents applied in the last 5 years. We discover 172 most active companies in this area. The fast-growing Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd. take 18.95% of patent filing during this period.
New York, United States
Patent: 57
Switzerland
Patent: 53
Jiangsu Sheng, China
Patent: 38
Shanghai Shi, China
Patent: 36
Israel
Patent: 22
Israel
Patent: 22
Tokyo-to, Japan
Patent: 21
ZURICH, Switzerland
Patent: 17
California, United States
Patent: 17
Israel
Patent: 15
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 781 patents in last 5 years, we discover 120 new entrants. Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Molecular Partners AG are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 38
Shanghai Shi, China
Patent: 36
ZURICH, Switzerland
Patent: 17
California, United States
Patent: 17
Beijing Shi, China
Patent: 14
STARTUP
Shanghai Shi, China
Patent: 12
Utrecht, Netherlands
Patent: 11
United Kingdom
Patent: 11
France
Patent: 10
New Jersey, United States
Patent: 10
Research Institutions
Order by:
Innovation Intensity
With the analysis among 241 patents, we discovered top 42 universities and scientific research institutions by total patent application. Dartmouth College, Baylor College of Medicine, The Rockefeller University are dominant in this area. They take 21.99% of the total patent filing.
New Hampshire, United States
Patent: 12
Texas, United States
Patent: 12
New York, United States
Patent: 10
France
Patent: 10
Colorado, United States
Patent: 10
Tianjin Shi, China
Patent: 10
Texas, United States
Patent: 9
Georgia, United States
Patent: 8
Antwerpen, Belgium
Patent: 8
Saudi Arabia
Patent: 8
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: